PI-3-Kinase Inhibitors in Colorectal Cancer

E-ISSN： 1873-5576|11|2|190-198

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.11, Iss.2, 2011-01, pp. : 190-198

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Computational Medicinal Chemistry to Design Novel Phosphoinositide 3- Kinase (PI3K) Alpha Inhibitors in View of Cancer

Current Bioactive Compounds, Vol. 10, Iss. 3, 2014-08 ,pp. : 147-157

Bentham Science Publishers

Access to resources Recommend Favorite

The PI3 Kinase Signaling Pathway in Prostate Cancer

Current Cancer Drug Targets, Vol. 13, Iss. 2, 2013-02 ,pp. : 157-164

Bentham Science Publishers

Access to resources Recommend Favorite

Protein kinase inhibitors in metastatic colorectal cancer. Let's pick patients, tumors, and kinase inhibitors to piece the puzzle together!

By Stintzing Sebastian Lenz Heinz-Josef

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 16, 2013-11 ,pp. : 2203-2220

Informa Healthcare

Access to resources Recommend Favorite

New phosphatidylinositol 3-kinase inhibitors for cancer

By Bowles Daniel W Jimeno Antonio

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 4, 2011-04 ,pp. : 507-518

Informa Healthcare

Access to resources Recommend Favorite

PI3K/AKT/mTOR Inhibitors In Ovarian Cancer

Current Medicinal Chemistry, Vol. 17, Iss. 36, 2010-12 ,pp. : 4433-4447

Bentham Science Publishers

Access to resources Recommend Favorite